Orthofix Medical Price To Book vs. Operating Margin
| OFIX Stock | USD 11.98 -0.29 -2.36% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.59 | 0.6709 |
|
|
The profitability panel for Orthofix Medical aligns margins and return ratios with revenue, assets, and operating costs.
Your Equity Center. Macro event markers
Earnings Share -2.33 | Revenue Per Share | Quarterly Revenue Growth 0.02 | Return On Assets | Return On Equity |
Orthofix Medical market price can diverge from book value, the accounting figure shown on Orthofix balance sheet. Orthofix Medical's market capitalization is 492.57 M. A P/B ratio of 1.09 indicates the market values Orthofix Medical above its accounting book value. Enterprise value stands at 588.98 M. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
It is useful to distinguish Orthofix Medical's value from its trading price, which are computed with different methods. For Orthofix Medical, key inputs include a P/E ratio of 338.0, a P/B ratio of 1.09, a profit margin of -11.21%, and ROE of -19.34%. The quoted price is simply the exchange level where supply meets demand.
Orthofix Medical Operating Margin vs. Price To Book Fundamental Analysis
Industry benchmarking evaluates Orthofix Medical's relative pricing strength. Orthofix Medical is rated below average. in price to book category among its top competitors. It maintains a fourth in operating margin category among its top competitors . Operating Profit Margin is projected to change by approximately 5.27% year over year. In the prior fiscal year, Operating Profit Margin was reported at -0.0833. Relative valuation frameworks compare Orthofix Medical across key financial ratios.Orthofix Medical's Historical Earnings Breakdown by Geography
Orthofix Operating Margin vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Orthofix Medical |
| = | 1.09 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Orthofix Medical |
| = | -0.01 % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Orthofix Operating Margin Comparison
Orthofix Medical is currently under evaluation. in operating margin category among its top competitors.
Orthofix Medical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Orthofix Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Orthofix Medical will eventually generate negative long term returns. The profitability progress is the general direction of Orthofix Medical's change in net profit over the period of time. It can combine multiple indicators of Orthofix Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 618 K | 866.6 K | |
| Operating Income | -68.5 M | -65 M | |
| Total Other Income Expense Net | -22.3 M | -21.2 M | |
| Net Loss | -92.2 M | -87.6 M | |
| Income Tax Expense | 1.4 M | 1.3 M | |
| Income Before Tax | -90.8 M | -86.3 M | |
| Net Loss | -17.8 M | -16.9 M | |
| Net Loss | -92.2 M | -87.6 M | |
| Non Operating Income Net Other | -2.5 M | -2.6 M | |
| Interest Income | 109.8 K | 104.3 K | |
| Net Interest Income | -17.5 M | -16.6 M | |
| Change To Netincome | 6.5 M | 6.2 M | |
| Net Loss | -2.31 | -2.20 | |
| Income Quality | -0.18 | -0.19 | |
| Net Income Per E B T | 1.02 | 0.55 |
Orthofix Profitability Driver Comparison
Profitability drivers are a critical input for any investor evaluating Orthofix Medical. Unexpected events - including regulatory changes, commodity price swings, and macroeconomic disruptions - can materially affect Orthofix Medical's profit outlook and significantly alter its long-term earnings trajectory.
Orthofix Medical Earnings Estimation Breakdown
The projected EPS for Orthofix Medical in the upcoming reporting period is 0.0, as estimated by professional analysts tracking Orthofix Medical. Individual analyst forecasts span from 0.0 to 0.0, indicating the range of analytical uncertainty. This consensus is derived from 12-month trailing data and is adjusted to remove non-recurring items.Last Reported EPS
0.00 Lowest | Expected EPS | 0.00 Highest |
Orthofix Medical Earnings Projection Consensus
The consensus EPS valuation model for Orthofix Medical generates an estimated fair value that investors compare to the prevailing market price. A favorable gap - estimate above price - may indicate potential upside; an unfavorable gap may indicate downside risk. Both signals are scenario-based and should be interpreted with appropriate caution and fundamental due diligence.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 30th of June 2026 | Current EPS (TTM) | |
| 5 | 46.32% | 0.0 | 0.0 | -2.33 |
Orthofix Medical Earnings History
Market participants use analyst EPS consensus for Orthofix Medical as the de facto benchmark for earnings performance. A result above consensus is called a beat; below is a miss. Both outcomes trigger swift market adjustments. For a complete picture, evaluate EPS trends alongside revenue quality and balance sheet indicators.Orthofix Medical Quarterly Gross Profit | 142.03 Million |
The mean reversion principle applied to Orthofix Medical's suggests that neither prolonged outperformance nor underperformance is permanent. Investors exploit this by positioning against extremes in price relative to fundamental value.
Earnings per Share Projection vs Actual
Orthofix Medical's actual EPS history reveals the company's underlying profit trend over time - a critical input for valuation. Expected EPS for Orthofix Medical reflects what seasoned analysts believe the company will earn, forming the consensus benchmark. We use weighted share count to ensure the profitability signal is not distorted by temporary changes in shares outstanding.Orthofix Medical Estimated Months Earnings per Share
EPS is an important lens for income investors in Orthofix Medical because it quantifies per-share earning power - the foundation of any sustainable dividend. A rising EPS trend paired with disciplined capital allocation suggests growing dividend capacity over time. Use EPS alongside cash flow statements and peer-relative payout ratios for the most complete income risk assessment.Orthofix Quarterly Analyst Estimates and Surprise Metrics
Each earnings release for Orthofix Medical is an inflection point where actual results are compared against what analysts projected. The surprise - whether a beat, miss, or in-line result - anchors the post-report narrative and near-term price path. Analyst EPS estimates are compiled through ongoing dialogue with management and bottom-up sector modeling.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
2026-02-24 | 2025-12-31 | -0.22 | 0.2378 | 0.4578 | 208 | ||
2025-11-04 | 2025-09-30 | -0.33 | -0.57 | -0.24 | 72 | ||
2025-08-05 | 2025-06-30 | -0.41 | -0.36 | 0.05 | 12 | ||
2025-05-05 | 2025-03-31 | -0.2667 | -1.3549 | -1.0882 | 408 | ||
2025-03-03 | 2024-12-31 | -0.05 | 0.0154 | 0.0654 | 130 | ||
2024-11-07 | 2024-09-30 | -0.15 | 0.07 | 0.22 | 146 | ||
2024-08-06 | 2024-06-30 | -0.19 | 0.05 | 0.24 | 126 | ||
2024-05-07 | 2024-03-31 | -0.33 | 0.11 | 0.44 | 133 | ||
2024-03-05 | 2023-12-31 | -0.08 | 0.02 | 0.1 | 125 | ||
2023-11-08 | 2023-09-30 | -0.21 | 0.07 | 0.28 | 133 | ||
2023-08-08 | 2023-06-30 | -0.47 | 0.02 | 0.49 | 104 | ||
2023-05-09 | 2023-03-31 | -0.51 | -0.1 | 0.41 | 80 | ||
2023-03-06 | 2022-12-31 | 0.1 | 0.19 | 0.09 | 90 | ||
2022-11-03 | 2022-09-30 | 0.12 | 0.13 | 0.01 | 8 | ||
2022-08-05 | 2022-06-30 | 0.1 | 0.08 | -0.02 | 20 | ||
2022-05-06 | 2022-03-31 | 0.09 | -0.1 | -0.19 | 211 | ||
2022-02-25 | 2021-12-31 | 0.13 | 0.27 | 0.14 | 107 | ||
2021-11-05 | 2021-09-30 | 0.11 | 0.1 | -0.01 | 9 | ||
2021-08-06 | 2021-06-30 | 0.11 | 0.32 | 0.21 | 190 | ||
2021-04-30 | 2021-03-31 | 0.02 | 0.17 | 0.15 | 750 | ||
2021-02-26 | 2020-12-31 | 0.19 | 0.44 | 0.25 | 131 | ||
2020-11-05 | 2020-09-30 | -0.36 | 0.31 | 0.67 | 186 | ||
2020-08-06 | 2020-06-30 | -1.08 | -0.59 | 0.49 | 45 | ||
2020-05-08 | 2020-03-31 | 0.06 | 0.09 | 0.03 | 50 | ||
2020-02-24 | 2019-12-31 | 0.58 | 0.51 | -0.07 | 12 | ||
2019-10-28 | 2019-09-30 | 0.51 | 0.41 | -0.1 | 19 | ||
2019-08-05 | 2019-06-30 | 0.42 | 0.28 | -0.14 | 33 | ||
2019-05-06 | 2019-03-31 | 0.36 | 0.27 | -0.09 | 25 | ||
2019-02-25 | 2018-12-31 | 0.48 | 0.55 | 0.07 | 14 | ||
2018-10-29 | 2018-09-30 | 0.36 | 0.43 | 0.07 | 19 | ||
2018-08-06 | 2018-06-30 | 0.36 | 0.42 | 0.06 | 16 | ||
2018-04-30 | 2018-03-31 | 0.37 | 0.39 | 0.02 | 5 | ||
2018-02-26 | 2017-12-31 | 0.5 | 0.52 | 0.02 | 4 | ||
2017-10-30 | 2017-09-30 | 0.38 | 0.42 | 0.04 | 10 | ||
2017-08-07 | 2017-06-30 | 0.37 | 0.42 | 0.05 | 13 | ||
2017-05-04 | 2017-03-31 | 0.29 | 0.27 | -0.02 | 6 | ||
2017-02-27 | 2016-12-31 | 0.37 | 0.42 | 0.05 | 13 | ||
2016-10-31 | 2016-09-30 | 0.31 | 0.36 | 0.05 | 16 | ||
2016-08-01 | 2016-06-30 | 0.33 | 0.41 | 0.08 | 24 | ||
2016-04-28 | 2016-03-31 | 0.15 | 0.28 | 0.13 | 86 | ||
2016-02-29 | 2015-12-31 | 0.23 | 0.28 | 0.05 | 21 | ||
2015-11-03 | 2015-09-30 | 0.13 | 0.3 | 0.17 | 130 | ||
2015-08-04 | 2015-06-30 | 0.09 | 0.36 | 0.27 | 300 | ||
2015-05-18 | 2015-03-31 | 0.08 | -0.15 | -0.23 | 287 | ||
2015-03-31 | 2014-12-31 | 0.3 | 0.15 | -0.15 | 50 | ||
null | null | null | null | null | 0 | ||
2014-05-07 | 2014-03-31 | 0.22 | 0.29 | 0.07 | 31 | ||
2014-03-24 | 2013-12-31 | 0.39 | 0.21 | -0.18 | 46 | ||
2013-10-21 | 2013-09-30 | 0.37 | -1.0925 | -1.4625 | 395 | ||
2013-05-08 | 2013-03-31 | 0.66 | 0.23 | -0.43 | 65 | ||
2013-02-21 | 2012-12-31 | 0.8 | 0.81 | 0.01 | 1 | ||
2012-10-24 | 2012-09-30 | 0.74 | 0.76 | 0.02 | 2 | ||
2012-07-26 | 2012-06-30 | 0.72 | 0.78 | 0.06 | 8 | ||
2012-04-26 | 2012-03-31 | 0.66 | 0.69 | 0.03 | 4 | ||
2012-02-23 | 2011-12-31 | 0.75 | 0.8 | 0.05 | 6 | ||
2011-10-27 | 2011-09-30 | 0.65 | 0.67 | 0.02 | 3 | ||
2011-07-28 | 2011-06-30 | 0.63 | 0.69 | 0.06 | 9 | ||
2011-05-05 | 2011-03-31 | 0.55 | 0.56 | 0.01 | 1 | ||
2011-02-15 | 2010-12-31 | 0.41 | 0.67 | 0.26 | 63 | ||
2010-10-27 | 2010-09-30 | 0.43 | 0.48 | 0.05 | 11 | ||
2010-07-28 | 2010-06-30 | 0.47 | 0.57 | 0.1 | 21 | ||
2010-04-28 | 2010-03-31 | 0.81 | 0.99 | 0.18 | 22 | ||
2010-02-17 | 2009-12-31 | 0.5 | 0.55 | 0.05 | 10 | ||
2009-10-29 | 2009-09-30 | 0.34 | 0.36 | 0.02 | 5 | ||
2009-07-30 | 2009-06-30 | 0.23 | 0.35 | 0.12 | 52 | ||
2009-05-06 | 2009-03-31 | 0.14 | 0.17 | 0.03 | 21 | ||
2009-02-12 | 2008-12-31 | 0.3 | -0.04 | -0.34 | 113 | ||
2008-11-06 | 2008-09-30 | 0.03 | -13.87 | -13.9 | 46333 | ||
2008-08-07 | 2008-06-30 | 0.3 | 0.34 | 0.04 | 13 | ||
2008-05-01 | 2008-03-31 | 0.09 | 0.21 | 0.12 | 133 | ||
2008-02-21 | 2007-12-31 | 0.62 | 0.41 | -0.21 | 33 | ||
2007-11-06 | 2007-09-30 | 0.48 | 0.48 | 0.0 | 0 | ||
2007-08-07 | 2007-06-30 | 0.43 | 0.43 | 0.0 | 0 | ||
2007-05-08 | 2007-03-31 | 0.38 | 0.37 | -0.01 | 2 | ||
2007-03-06 | 2006-12-31 | 0.4 | 0.44 | 0.04 | 10 | ||
2006-10-26 | 2006-09-30 | 0.53 | -1.17 | -1.7 | 320 | ||
2006-07-27 | 2006-06-30 | 0.57 | 0.79 | 0.22 | 38 | ||
2006-04-27 | 2006-03-31 | 0.47 | 0.51 | 0.04 | 8 | ||
2006-02-28 | 2005-12-31 | 0.51 | 0.44 | -0.07 | 13 | ||
2005-10-27 | 2005-09-30 | 0.53 | 0.48 | -0.05 | 9 | ||
2005-07-28 | 2005-06-30 | 0.59 | 0.58 | -0.01 | 1 | ||
2005-04-28 | 2005-03-31 | 0.56 | 0.67 | 0.11 | 19 | ||
2005-03-03 | 2004-12-31 | 0.59 | 0.59 | 0.0 | 0 | ||
2004-10-28 | 2004-09-30 | 0.54 | 0.53 | -0.01 | 1 | ||
2004-07-27 | 2004-06-30 | 0.54 | 0.5 | -0.04 | 7 | ||
2004-05-03 | 2004-03-31 | 0.55 | 0.53 | -0.02 | 3 | ||
2004-02-26 | 2003-12-31 | 0.5 | 0.52 | 0.02 | 4 | ||
2003-10-28 | 2003-09-30 | 0.34 | 0.37 | 0.03 | 8 | ||
2003-07-24 | 2003-06-30 | 0.48 | 0.44 | -0.04 | 8 | ||
2003-04-25 | 2003-03-31 | 0.43 | 0.41 | -0.02 | 4 | ||
2002-07-25 | 2002-06-30 | 0.45 | 0.45 | 0.0 | 0 | ||
2002-04-25 | 2002-03-31 | 0.44 | 0.44 | 0.0 | 0 | ||
2002-02-28 | 2001-12-31 | 0.4 | 0.4 | 0.0 | 0 | ||
2001-07-26 | 2001-06-30 | 0.35 | 0.35 | 0.0 | 0 | ||
2001-04-26 | 2001-03-31 | 0.35 | 0.35 | 0.0 | 0 | ||
2001-02-28 | 2000-12-31 | 0.34 | 0.34 | 0.0 | 0 | ||
2000-10-26 | 2000-09-30 | 0.28 | 0.28 | 0.0 | 0 | ||
2000-07-27 | 2000-06-30 | 0.29 | 0.3 | 0.01 | 3 | ||
2000-04-27 | 2000-03-31 | 0.27 | 0.3 | 0.03 | 11 | ||
2000-02-24 | 1999-12-31 | 0.26 | 0.29 | 0.03 | 11 | ||
1999-10-28 | 1999-09-30 | 0.23 | 0.23 | 0.0 | 0 | ||
1999-07-28 | 1999-06-30 | 0.21 | 0.24 | 0.03 | 14 | ||
1999-04-28 | 1999-03-31 | 0.18 | 0.21 | 0.03 | 16 | ||
1999-03-10 | 1998-12-31 | 0.21 | 0.22 | 0.01 | 4 | ||
1998-10-27 | 1998-09-30 | 0.17 | 0.18 | 0.01 | 5 | ||
1998-07-29 | 1998-06-30 | 0.16 | 0.1 | -0.06 | 37 | ||
1998-04-27 | 1998-03-31 | 0.14 | 0.13 | -0.01 | 7 | ||
1998-03-05 | 1997-12-31 | 0.18 | 0.18 | 0.0 | 0 | ||
1997-10-27 | 1997-09-30 | 0.11 | 0.13 | 0.02 | 18 | ||
1997-05-06 | 1997-03-31 | 0.05 | 0.03 | -0.02 | 40 | ||
1997-03-13 | 1996-12-31 | 0.09 | 0.03 | -0.06 | 66 | ||
1996-10-23 | 1996-09-30 | 0.11 | 0.03 | -0.08 | 72 | ||
1996-07-25 | 1996-06-30 | 0.06 | 0.05 | -0.01 | 16 | ||
1996-04-25 | 1996-03-31 | 0.1 | 0.02 | -0.08 | 80 | ||
1996-03-13 | 1995-12-31 | 0.06 | -0.17 | -0.23 | 383 | ||
1995-10-30 | 1995-09-30 | 0.25 | 0.09 | -0.16 | 64 | ||
1995-07-21 | 1995-06-30 | 0.24 | 0.24 | 0.0 | 0 | ||
1995-04-25 | 1995-03-31 | 0.24 | 0.27 | 0.03 | 12 | ||
1995-03-02 | 1994-12-31 | 0.21 | 0.25 | 0.04 | 19 | ||
1994-10-27 | 1994-09-30 | 0.2 | 0.2 | 0.0 | 0 | ||
1994-07-28 | 1994-06-30 | 0.21 | 0.19 | -0.02 | 9 | ||
1994-04-25 | 1994-03-31 | 0.21 | 0.2 | -0.01 | 4 |
Use Orthofix Medical in pair-trading
Pair trading with Orthofix Medical can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Orthofix Medical Pair Trading
Orthofix Medical Pair Trading Analysis
Finding correlated alternatives to Orthofix Medical is a practical necessity for tax-aware investors. The wash-sale rule prohibits repurchasing Orthofix Medical within 30 days of a loss sale, making it essential to identify substitute holdings with similar risk profiles.
The statistical relationship between Orthofix Medical and other instruments is summarized by the correlation coefficient. Investors use this measure to identify whether adding a new position would truly diversify a portfolio already containing Orthofix Medical.
Use Correlation analysis and pair trading evaluation for Orthofix Medical to review hedging context. The approach can be applied within sectors or across broader universes.Use Investing Themes to Complement your Orthofix Medical position
Using Orthofix Medical inside a theme workflow gives investors a structured way to compare related stocks, funds, ETFs, and crypto assets before allocating capital. The practical benefit is that the selected idea can be tuned either for higher upside or for tighter risk control.
Did You Try This Idea?
Run Manufacturing Thematic Idea Now
Manufacturing
Companies that provide goods across residential, commercial and industrial construction such as machinery, tools, or lumber production. The Manufacturing theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Manufacturing Theme or any other thematic opportunities.
| View All Next | Launch |
More Resources for Orthofix Stock Analysis
Understanding Orthofix Medical typically begins with financial statements and long-term trend review. Ratio context helps frame profitability, efficiency, and growth trends for Orthofix Medical Stock. Outlined below are key reports that provide context for Orthofix Medical Stock:Your Equity Center. New to investing in Orthofix Stock? Start with our How to Invest in Orthofix Stock guide for a step-by-step overview.Analysis related to Orthofix Medical should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Projecting Orthofix Medical's profitability begins with historical financial statements. Core documents include the income statement, balance sheet, and cash-flow statement.